CATHERINE TEESELINK
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ANCHORAGE, AK NPI 1992472161
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AK Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,289.85
- Category: General Payments
- Program years: PY2022–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $805.16 across 28 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.16 | 27 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $165.81 | 3 |
| Janssen Biotech, Inc. | $119.18 | 2 |
| ABBVIE INC. | $45.66 | 2 |
| Deciphera Pharmaceuticals Inc. | $42.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $36.77 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.27 | 2 |
| Rigel Pharmaceuticals, Inc. | $33.72 | 1 |
| Astellas Pharma US Inc | $31.25 | 1 |
| TerSera Therapeutics LLC | $30.18 | 1 |
| GENZYME CORPORATION | $27.09 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.22 | 1 |
| Daiichi Sankyo Inc. | $25.18 | 1 |
| PFIZER INC. | $23.54 | 1 |
| Genentech USA, Inc. | $22.50 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $20.64 | 1 |
| Exelixis Inc. | $19.41 | 1 |
| Merck Sharp & Dohme Corporation | $19.29 | 1 |
| Karyopharm Therapeutics Inc. | $19.20 | 1 |
| ARRAY BIOPHARMA INC | $16.79 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.71 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.46 | 1 |
| Lilly USA, LLC | $13.29 | 1 |
By program year
Records — PY2024 (28)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.